ROCA, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 4.147
EU - Europa 1.298
AS - Asia 1.016
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 6.474
Nazione #
US - Stati Uniti d'America 4.136
CN - Cina 513
UA - Ucraina 367
DE - Germania 270
SG - Singapore 253
HK - Hong Kong 141
IT - Italia 132
RU - Federazione Russa 110
GB - Regno Unito 94
FI - Finlandia 82
TR - Turchia 77
IE - Irlanda 73
PL - Polonia 52
CZ - Repubblica Ceca 35
FR - Francia 35
BE - Belgio 18
CA - Canada 11
SE - Svezia 10
VN - Vietnam 10
NL - Olanda 9
IN - India 7
AU - Australia 6
IR - Iran 5
EU - Europa 4
ID - Indonesia 3
BG - Bulgaria 2
DK - Danimarca 2
ES - Italia 2
TW - Taiwan 2
AM - Armenia 1
BD - Bangladesh 1
EE - Estonia 1
GR - Grecia 1
JP - Giappone 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MU - Mauritius 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 6.474
Città #
Fairfield 755
Woodbridge 391
Ashburn 335
Jacksonville 316
Houston 306
Seattle 285
Cambridge 257
Wilmington 248
Singapore 221
Chandler 201
Ann Arbor 179
Princeton 146
Hong Kong 140
Beijing 114
Nanjing 102
Helsinki 79
Dublin 73
Istanbul 69
New York 65
Dearborn 64
Warsaw 52
Des Moines 35
Nanchang 35
Changsha 32
Moscow 32
Hebei 29
San Diego 29
Brescia 28
Shanghai 28
Shenyang 24
Brno 22
Boardman 19
Brussels 18
Jinan 18
San Mateo 18
Tianjin 15
London 13
Olomouc 13
Jiaxing 12
Nürnberg 12
Kunming 11
Zhengzhou 11
Dong Ket 10
Los Angeles 9
Toronto 9
Falls Church 8
Munich 8
Ningbo 8
Taizhou 8
Augusta 7
Hangzhou 7
Lanzhou 7
Kilburn 6
Lancaster 6
Milan 6
Napoli 6
Washington 6
Ardabil 5
Guangzhou 5
Haikou 5
San Francisco 5
Canberra 4
Falkenstein 4
Hefei 4
Leawood 4
Monmouth Junction 4
Norwalk 4
Orange 4
Rovato 4
Vignate 4
Alessandria 3
Fuzhou 3
Hounslow 3
Jakarta 3
Kocaeli 3
Parma 3
Redwood City 3
Rome 3
Trieste 3
Acton 2
Barcelona 2
Cassina de' Pecchi 2
Chicago 2
Chiswick 2
Ferrara 2
Gavardo 2
Highland 2
Iseo 2
Magdeburg 2
Melbourne 2
New Bedfont 2
Ottawa 2
Pisogne 2
Rende 2
Sant'anastasia 2
Sofia 2
Southwark 2
Stockholm 2
Verona 2
Almere Stad 1
Totale 5.087
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 192
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case 151
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 149
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 148
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 146
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 144
Acute functional reactivation of the language network during awake intraoperative brain mapping 143
Regression of advanced neuroendocrine tumors among patients receiving placebo 141
Palbociclib inhibits proliferation of human adrenocortical tumor cells 138
Effects of CPAP on systemic hypertension in OSAH: a monocentric, observational, cohort study 135
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 133
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 132
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 132
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 131
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 130
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 130
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy 129
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 127
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options 126
Serum vitamin D and prostate cancer prognosis: The story continues 123
Detection of serum proteomic profile predictive for epidermal growth factor receptor tyrosine kinase inihibitors (EGFR-TKIs) in 1st line chemotherapy responders 123
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 119
Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations 119
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient 118
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 114
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 114
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice 113
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 111
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 110
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 110
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions 109
CT texture analysis as predictive factor in metastatic lung adenocarcinoma treated with tyrosine kinase inhibitors (TKIs) 109
Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: Prediction of the response to the first-line chemotherapy 100
Positive FDG-PET/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcoma 98
Detection of EpCAM-positive microparticles in pleural fluid: A new approach to mini-invasively identify patients with malignant pleural effusions 95
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 95
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME) 95
How to Improve Effectiveness and Adherence to Antihypertensive Drug Therapy: Central Role of Dihydropyridinic Calcium Channel Blockers in Hypertension 92
Malignant pleural mesothelioma: from the bench to the bedside 90
Listening understanding and acting (lung): Focus on communicational issue in thoracic oncology 90
Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies 88
Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer 85
Prognostic and predictive value of histogram analysis in patients with non-small cell lung cancer refractory to platinum treated by nivolumab: A multicentre retrospective study 81
Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It? 81
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions 80
False Negative Pleural Cytology in Patient with Malignant Pleurisies: Is Pleural EpCAM-Positive Microparticles a Complementary Tool for Diagnosis? 76
Malignant pleural mesothelioma signs and symptoms 74
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 70
Onde elettromagnetiche ad alta frequenza e bassa intensit. nel trattamento delle ulcere cutanee: 8 casi clinici. 67
18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography fused imaging in malignant mesothelioma patients: looking from outside is not enough 63
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 62
Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study 61
Echocardiographic evaluation in subjects with (1)-Antitrypsin deficiency 60
Pathologie pleurale 59
CT scanner for the pleural staging of pleural cancer: How accurate is this? 57
ASTRIS, a real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC): preliminary analysis of the Italian cohort 55
THE ASSOCIATION BETWEEN PROTEOMIC PROFILE DETECTED BEFORE 2ND/3RD LINE EGFR-TKIS AND RESPONSE TO 1ST LINE CHEMOTHERAPY 51
Multigene mutation analysis of mediastinal and hilar lymph nodes sampled by endobronchial unltrasound-guided needle aspiration 46
IMPACT OF CLINICAL PARAMETERS ON OUTCOME OF PATIENTS TREATED WITH GAMMA KNIFE STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER 43
CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer 42
Onde elettromagnetiche ad alta frequenza e bassa intensità nel trattamento delle ulcere cutanee: 8 casi clinici 40
Thoracic Cytological Specimens Obtained In Routine Clinical Practice And EGFR, Kras, Her2, Braf And Pi3kca Mutation Status In Metastatic Cancer Patients 39
PROTEOMIC SIGNATURE TO IMPROVE OUTCOME IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH EGFR-TKIS 38
EGFR, KRAS, HER2, BRAF and PI3KCA mutation status in metastatic cancer patients: Thoracic cytological specimens obtained in routine clinical practice 38
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation 38
Maintenance with Lanreotide in SCLC Patients, Expressing Somatostatine Receptors, after Response to First Line Therapy 37
Tissue factor positive microparticles remain undetectable by flow cytometry in pleural fluids from cancer patients despite high level of procoagulant activity 36
Multigene Mutation Analysis Of Mediastinal Lymph Nodes Assessed By Endobronchial Ultrasound-Guided Needle Aspiration: A Prospective Study 31
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis 26
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 24
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial 22
Is DNA repair a potential target for effective therapies against malignant mesothelioma? 21
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis 19
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study 15
Totale 6.629
Categoria #
all - tutte 33.777
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.777


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.283 0 0 0 0 0 234 259 217 176 219 91 87
2020/20211.291 41 147 86 146 77 115 47 134 110 164 156 68
2021/2022592 38 66 33 45 9 36 21 63 25 72 47 137
2022/2023589 85 24 16 44 53 130 3 74 105 1 24 30
2023/2024618 47 22 63 34 33 91 19 21 154 9 6 119
2024/2025470 20 5 8 199 145 93 0 0 0 0 0 0
Totale 6.629